NCT05107700View on ClinicalTrials.gov

Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500m

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

April 15, 2022

Study Completion Date

April 15, 2022

Conditions
High Altitude Pulmonary Hypertension
Interventions
PROCEDURE

Stay at altitude 2500 m above sea level (high altitude)

Patients with precapillary pulmonary hypertension stay a sojourn of 30 h at 2500 m.

PROCEDURE

Stay at altitude 470 m above sea level (low altitude)

Patients with precapillary pulmonary hypertension stay a sojourn of 30 h at 470 m.

Trial Locations (1)

8091

University Hospital of Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT05107700 - Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500m | Biotech Hunter | Biotech Hunter